Alnylam Pharmaceuticals, Inc. (ALNY)
320.66
+0.15
(+0.05%)
USD |
NASDAQ |
Mar 06, 16:00
319.45
-1.21
(-0.38%)
After-Hours: 20:00
Alnylam Pharmaceuticals SG&A Expense (TTM) : 1.211B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 701.17M |
| Biogen, Inc. | 2.434B |
| Pfizer Inc. | 13.79B |
| Eli Lilly & Co. | 11.09B |
| AbbVie, Inc. | 14.01B |